Abiopharma

🔍 Netzly Kyle (Executive)

Company: Groupon, Inc. (GRPN)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 4,950 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,917.00 | transaction_form_type: 4
• Sold 2,045 shares of Common Stock at $27.89 per share (Direct)
  Date: 2026-07-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 33,872.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,950 shares of Performance Share Units (Derivative)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 55,050.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Shares withheld to satisfy the mandatory tax withholding requirement upon the vesting of performance share units ("PSUs"). This is not an open market sale of securities.
• F2: Each PSU represents a contingent right to receive one share of Groupon, Inc. (the "Issuer") common stock.
• F3: The number of shares of common stock that will be acquired on vesting of the PSUs is contingent upon: (1) the achievement of pre-established stock price hurdles over a three-year performance period beginning on May 1, 2025, and ending on May 1, 2028; and (2) the achievement of continued service conditions measured on each of May 1, 2026, May 1, 2027, and May 1, 2028. The PSUs shall vest immediately upon certification of the achievement of both conditions by the Compensation Committee of the Issuer's Board of Directors (the "Committee"). On July 30, 2026, the Committee certified that the first pre-established stock price hurdle and the continued service condition measured as of May 1, 2026 have both been achieved, and 4,950 PSUs vested on July 30, 2026.